GLP-1 Prescription and Pregnancy: What Women Need to Know

GLP-1 medications are contraindicated during pregnancy. This isn't a gray area — it's a clear FDA directive. But the questions surrounding pregnancy planning, fertility effects, and postpartum restart are more nuanced than the labels suggest.

Why GLP-1s Are Contraindicated in Pregnancy

Animal studies showed adverse fetal outcomes (reduced growth, structural abnormalities) at doses proportionally similar to human therapeutic doses. No adequate human pregnancy studies exist because enrolling pregnant women in drug trials is ethically restricted. The FDA classified both semaglutide and tirzepatide as pregnancy risk based on animal data — the standard regulatory approach when human data is absent.

The Fertility Paradox

GLP-1 medications can restore fertility in women who were previously sub-fertile due to obesity-related hormonal dysfunction. Weight loss normalizes estrogen, progesterone, and luteinizing hormone levels. PCOS symptoms improve. Ovulation may resume in women who hadn't been ovulating regularly. This has led to the “Ozempic babies” phenomenon — unplanned pregnancies in women who didn't realize their fertility had returned.

Planning for Pregnancy

The recommended washout period before attempting conception is at least 2 months for semaglutide (approximately 5 half-lives for complete clearance) and at least 1 month for tirzepatide. Some providers recommend longer washout periods of 2–3 months as an extra precaution. Discuss your timeline with both your GLP-1 provider and your OB-GYN.

Contraception on GLP-1

Tirzepatide reduces oral contraceptive absorption by approximately 20%. If you're on tirzepatide, switch to a non-oral contraceptive method or add a barrier method. Semaglutide does not appear to affect oral contraceptive efficacy.

Postpartum Restart

GLP-1 medications should not be taken during breastfeeding — it's unknown whether they pass into breast milk. After weaning, you can restart GLP-1 treatment. You'll likely need to re-titrate from a lower dose, especially if the gap was several months.